Using e-Nose Technology to Identify Early Lung Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

119

Participants

Timeline

Start Date

January 25, 2021

Primary Completion Date

January 25, 2026

Study Completion Date

January 25, 2026

Conditions
Lung; NodeLung Cancer
Interventions
DIAGNOSTIC_TEST

Breathprinting test

Consented, enrolled participants will undergo a breathprinting test (e-nose) during the presurgical visit and at the same facility as their presurgical or prebiopsy visit, before any attempt is made to obtain cytohistological diagnosis of the pulmonary nodule.

Trial Locations (7)

10065

Memorial Sloan Kettering Cancer Center (All Study Activities), New York

10604

Memorial Sloan Kettering Westchester (Consent only), Harrison

11553

Memorial Sloan Kettering Nassau (Consent Only), Uniondale

11725

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only), Commack

07920

Memorial Sloan Kettering Basking Ridge (Consent only), Basking Ridge

07748

Memorial Sloan Kettering Monmouth (Consent only), Middletown

07645

Memorial Sloan Kettering Bergen (Consent only ), Montvale

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER